<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0278009</article-id>
<article-id pub-id-type="publisher-id">PONE-D-22-30713</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Vesicles</subject><subj-group><subject>Endosomes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Cell membranes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject><subj-group><subject>Specimen preparation and treatment</subject><subj-group><subject>Staining</subject><subj-group><subject>Cell staining</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject><subj-group><subject>Specimen preparation and treatment</subject><subj-group><subject>Staining</subject><subj-group><subject>Cytoplasmic staining</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Probability theory</subject><subj-group><subject>Probability distribution</subject><subj-group><subject>Normal distribution</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Computer and information sciences</subject><subj-group><subject>Software engineering</subject><subj-group><subject>Computer software</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Engineering and technology</subject><subj-group><subject>Software engineering</subject><subj-group><subject>Computer software</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject><subj-group><subject>Specimen preparation and treatment</subject><subj-group><subject>Staining</subject><subj-group><subject>Nuclear staining</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Automated segmentation and quantitative analysis of organelle morphology, localization and content using CellProfiler</article-title>
<alt-title alt-title-type="running-head">Automated cell and organelle quantifications using CellProfiler</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9206-8712</contrib-id>
<name name-style="western">
<surname>Laan</surname>
<given-names>Sebastiaan N. J.</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
<role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Dirven</surname>
<given-names>Richard J.</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bürgisser</surname>
<given-names>Petra E.</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Eikenboom</surname>
<given-names>Jeroen</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
<role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1205-9689</contrib-id>
<name name-style="western">
<surname>Bierings</surname>
<given-names>Ruben</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
<role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<collab>for the SYMPHONY consortium</collab>
<xref ref-type="fn" rid="fn001"><sup>¶</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Alfonso</surname>
<given-names>Julieta</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University Hospital Heidelberg: UniversitatsKlinikum Heidelberg, GERMANY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="other" id="fn001">
<p>¶ The complete membership of the author group (SYMPHONY consortium) can be found in the Acknowledgments.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">r.bierings@erasmusmc.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>6</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>18</volume>
<issue>6</issue>
<elocation-id>e0278009</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>5</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-year>2023</copyright-year>
<copyright-holder>Laan et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0278009"/>
<abstract>
<p>One of the most used and versatile methods to study number, dimensions, content and localization of secretory organelles is confocal microscopy analysis. However, considerable heterogeneity exists in the number, size and shape of secretory organelles that can be present in the cell. One thus needs to analyze large numbers of organelles for valid quantification. Properly evaluating these parameters requires an automated, unbiased method to process and quantitatively analyze microscopy data. Here, we describe two pipelines, run by CellProfiler software, called OrganelleProfiler and OrganelleContentProfiler. These pipelines were used on confocal images of endothelial colony forming cells (ECFCs), which contain unique secretory organelles called Weibel-Palade bodies (WPBs), and on early endosomes in ECFCs and human embryonic kidney 293T (HEK293T) cells. Results show that the pipelines can quantify the cell count, size, organelle count, organelle size, shape, relation to cells and nuclei, and distance to these objects in both endothelial and HEK293T cells. Additionally, the pipelines were used to measure the reduction in WPB size after disruption of the Golgi and to quantify the perinuclear clustering of WPBs after triggering of cAMP-mediated signaling pathways in ECFCs. Furthermore, the pipeline is able to quantify secondary signals located in or on the organelle or in the cytoplasm, such as the small WPB GTPase Rab27A. Cell profiler measurements were checked for validity using Fiji. To conclude, these pipelines provide a powerful, high-processing quantitative tool for the characterization of multiple cell and organelle types. These pipelines are freely available and easily editable for use on different cell types or organelles.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003246</institution-id>
<institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution>
</institution-wrap>
</funding-source>
<award-id>NWA.1160.18.038</award-id>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009425</institution-id>
<institution>Landsteiner Foundation for Blood Transfusion Research</institution>
</institution-wrap>
</funding-source>
<award-id>LSBR-1707</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1205-9689</contrib-id>
<name name-style="western">
<surname>Bierings</surname>
<given-names>Ruben</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This research received funding from the Netherlands Organization for Scientific Research (NWO) in the framework of the NWA-ORC Call grant agreement NWA.1160.18.038 <ext-link ext-link-type="uri" xlink:href="https://symphonyconsortium.nl/" xlink:type="simple">https://symphonyconsortium.nl/</ext-link> (SYMPHONY: personalized treatment for patients with a bleeding disorder) (received by SNJL, RB and JE) and from the Landsteiner Stichting voor Bloedtransfusie Research (LSBR-1707) <ext-link ext-link-type="uri" xlink:href="https://lsbr.nl/" xlink:type="simple">https://lsbr.nl/</ext-link> (received by RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<page-count count="18"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All images and raw data files are available from the Zenodo database (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.7875537" xlink:type="simple">10.5281/zenodo.7875537</ext-link>).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Eukaryotic cells are compartmentalized into organelles, subcellular entities separated from the cytoplasm by a limiting membrane that enable them to more efficiently carry out specialized functions in the cell, such as energy production and protein synthesis, transport and degradation. A specific class of organelles consists of secretory vesicles, which serve to temporarily store and then rapidly secrete molecules into the extracellular space on demand. Secretory organelles are vital to maintaining homeostasis, as they allow a cell to communicate with other, distant cells or to respond to immediate changes in its environment, such as in the case of injury or when encountering pathogens. Their function is often defined by the content that is secreted, which is cell type and context specific, and depends on a sufficient magnitude of release, which directly relates to the number and dimensions of the secretory organelles that can undergo exocytosis. Moreover, the intracellular location of secretory organelles in relation to their site of biogenesis (i.e. the Golgi apparatus), filaments of the cytoskeleton and the plasma membrane also indirectly determines their exocytotic behavior.</p>
<p>Weibel-Palade bodies (WPBs) are cigar-shaped endothelial cell specific secretory organelles that contain a cocktail of vasoactive molecules that are released into the circulation in response to vascular injury or stress [<xref ref-type="bibr" rid="pone.0278009.ref001">1</xref>]. WPBs owe their typical elongated morphology to the condensation of its main cargo protein, the hemostatic protein Von Willebrand factor (VWF), into organized parallel tubules that unfurl into long platelet-adhesive strings upon release [<xref ref-type="bibr" rid="pone.0278009.ref002">2</xref>]. The size and shape of WPBs are of interest from a biological and medical perspective as they correlate with the hemostatic activity of the VWF strings that are released [<xref ref-type="bibr" rid="pone.0278009.ref003">3</xref>] and can be reflective of disease states, such as in the bleeding disorder Von Willebrand Disease (VWD) [<xref ref-type="bibr" rid="pone.0278009.ref004">4</xref>]. A model frequently used to study the pathophysiology of vascular diseases like VWD is the endothelial colony forming cell (ECFC). A major advantage of this model is that ECFCs can be derived from whole blood of patients, which allows analysis of patient endothelial cell function, WPB morphology and secretion <italic>ex vivo</italic>. However, substantial phenotypic heterogeneity can exist between ECFCs [<xref ref-type="bibr" rid="pone.0278009.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>], which stresses the need for robust quantitative analytical methods to evaluate their phenotype.</p>
<p>One of the most used and versatile methods to study number, dimensions, content and localization of secretory organelles is confocal microscopy analysis. However, as with all biological samples, considerable variability exists in the number, size and shapes of secretory organelles that can be present in the cell. One thus needs to analyze large numbers of organelles while ideally collecting this information in such a manner that it can be analyzed in a cell-by-cell manner. The crowded intracellular environment in combination with optical and immunostaining limitations presents an additional, technical challenge to separate individual organelles, which often precludes analysis on single organelle detail. Proper evaluation of these parameters requires an automated, unbiased method to process and quantitatively analyze microscopy data.</p>
<p>Here we describe 2 pipelines developed in CellProfiler [<xref ref-type="bibr" rid="pone.0278009.ref007">7</xref>], a free, easy to use image analysis software that uses separate module-based programming, for the identification, quantification and morphological analysis of secretory organelles within endothelial cells. The automated analysis pipeline OrganelleProfiler (OP) segments cells, organelles, nuclei and cell membranes from microscopy images, quantifies number, location, size and shape of organelles and extracts these data per cell and relative to the location of nucleus and perimeter of the cell. The function of the OrganelleProfiler pipeline is demonstrated by automated analysis of WPBs in 2 previously established phenotypic classes of healthy donor ECFCs [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>], which identifies clear differences in number, length, eccentricity and intracellular localization of WPBs, and by morphometric analysis of early endosomes in ECFCs and HEK293T cells. Furthermore, the OrganelleProfiler was able to measure reduction in WPB size after Golgi ribbon disruption and to quantify perinuclear clustering of WPBs after stimulation with cAMP-mediated agonists. A second pipeline, called OrganelleContentProfiler (OCP), expands on the capabilities of the OrganelleProfiler by offering additional modules to measure the intensity of proteins of the secretory pathway both inside and outside the WPB, which we illustrate by analyzing the presence of the WPB GTPase Rab27A [<xref ref-type="bibr" rid="pone.0278009.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0278009.ref010">10</xref>] and the endoplasmic reticulum marker protein disulfide isomerase (PDI).</p>
<p>Our CellProfiler pipelines provide robust and unbiased quantitative analysis tools for WPB morphometrics and can, with minimal adaptation, also be used to obtain quantitative data for other organelles and/or other cellular systems.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials &amp; methods</title>
<sec id="sec003">
<title>Endothelial colony forming cells and ethical approval</title>
<p>The study protocols for acquisition of ECFCs were approved by the Leiden University Medical Center and Erasmus MC ethics review boards. Informed consent was obtained from 4 subjects in accordance with the Declaration of Helsinki. Healthy participants were 18 years or older and had not been diagnosed with or known to have VWD or any other bleeding disorder. ECFCs used in this study have previously been classified as group 1 or group 3 [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>].</p>
</sec>
<sec id="sec004">
<title>Cell culture, immunofluorescence and image acquisition</title>
<p>General cell culture of Endothelial Colony Forming Cells (ECFCs) and HEK293T cells was performed as described [<xref ref-type="bibr" rid="pone.0278009.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0278009.ref011">11</xref>]. ECFCs and HEK293T cells were grown on gelatin- or collagen-coated glass coverslips (9mm) and left confluent for 5 days before fixing with 70% methanol on ice for 10 minutes or with 4% paraformaldehyde for 15 minutes as described previously [<xref ref-type="bibr" rid="pone.0278009.ref010">10</xref>]. Disruption of Golgi ribbons was done by exposure of ECFCs to 2 μg/ml of nocodazole (Sigma, M1404) for 46 hours. For triggering of cAMP-mediated signaling to induce perinuclear clustering of WPBs, post-confluent monolayers of ECFCs were treated with 10 μM Forskolin (Merck, F3917) and 100 μM 3-isobutyl-1-methylxanthine (IBMX) (Merck, I5879) for 30 minutes as described previously [<xref ref-type="bibr" rid="pone.0278009.ref012">12</xref>]. Samples for OrganelleProfiler were stained with antibodies against VWF, EEA1, VE‐cadherin, β-catenin, TGN46 and nuclei were stained with Hoechst or DAPI (<xref ref-type="supplementary-material" rid="pone.0278009.s001">S1 Table</xref> for supporting information on antibodies). Samples for OrganelleContentProfiler were stained with Hoechst and antibodies against VWF, VE-cadherin and either Rab27A or PDI. After staining with appropriate fluorescently labeled secondary antibodies, coverslips were mounted using ProLong<sup>®</sup> Diamond Antifade Mountant (Thermo Fisher Scientific). Visualization of the cells for the OrganelleProfiler example was done using the Imagexpress Micro Confocal System using the 63x objective without magnification or with the Leica Stellaris 5 Low Incidence Angle using the 63x oil immersion objective. The OrganelleContentProfiler samples were imaged using the Zeiss LSM900 Airyscan2 upright confocal microscope using the 63x oil immersion objective. For both the OrganelleProfiler and OrganelleContentProfiler images a Z-stack was made which was transformed to a maximum Z-projection.</p>
</sec>
<sec id="sec005">
<title>CellProfiler-based pipelines for cell organelle analysis and manual scoring with Fiji</title>
<p>CellProfiler (version 4.2.1 at time of publication) was used, which can be downloaded from the CellProfiler website (<ext-link ext-link-type="uri" xlink:href="http://www.cellprofiler.org" xlink:type="simple">www.cellprofiler.org</ext-link>). For the initial development of the pipelines, confocal images from 33 ECFC clones from several healthy donors were used. These ECFCs have previously been classified into separate phenotypic groups based on cellular morphology [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>]. The final pipeline was tested on 5 tile scans from one group 1 and one clone belonging to group 3. Images have to be of high enough resolution that individual organelles can be identified and do not blur together. Magnification, laser intensity, detector sensitivity and other acquisition parameters should be the same for each image set. Image format has to be similar as well. We recommend uncompressed TIFF files. Pipelines developed are available in <xref ref-type="supplementary-material" rid="pone.0278009.s002">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0278009.s003">S2</xref> Files and have been deposited in our laboratory GitHUB repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/Clotterdam" xlink:type="simple">https://github.com/Clotterdam</ext-link>). Adjusted pipelines optimized for the use on endosome quantification (in HEK293T cells—<xref ref-type="supplementary-material" rid="pone.0278009.s004">S3 File</xref> and in ECFCs–<xref ref-type="supplementary-material" rid="pone.0278009.s005">S4 File</xref>), WPB quantification after Golgi ribbon disruption (<xref ref-type="supplementary-material" rid="pone.0278009.s006">S5 File</xref>) and after forskolin stimulation (<xref ref-type="supplementary-material" rid="pone.0278009.s007">S6 File</xref>) are also made available. To compare the CellProfiler measurements and validate these, manual scoring of cell count, cell surface area, WPB count, WPB length, and VWF and Rab27A intensity inside and outside the WPBs was performed using Fiji version 2.3.0 [<xref ref-type="bibr" rid="pone.0278009.ref013">13</xref>]. Scoring was performed by using the built in scale and drawing regions of interest per cell and per WPB.</p>
</sec>
<sec id="sec006">
<title>Statistical analysis</title>
<p>Output data of the OrganelleProfiler pipeline was compared by Mann-Whitney U test if data was not normally distributed and unpaired T test with Welch’s correction was performed on normally distributed data. Data of the OrganelleContentProfiler pipeline was compared with RM one way ANOVA with Geisser-Greenhouse correction. Data are presented as median with min/max boxplot. Results with p value &lt; 0.05 were considered statistically significant. P values are indicated on the graphs in the figures. Data analyses were performed using GraphPad Prism 9.3.1 (GraphPad Software, San Diego, CA, USA).</p>
</sec>
</sec>
<sec id="sec007" sec-type="results">
<title>Results</title>
<sec id="sec008">
<title>Development of OrganelleProfiler (OP)—Automated identification and quantification of nuclei, cells and secretory organelles</title>
<p>Described here are the modules used in the OrganelleProfiler pipeline for the identification and measurement of endothelial cells, their nuclei and WPBs. The most important parameters and how these can be adjusted for use on other tissues for each module are mentioned in <xref ref-type="supplementary-material" rid="pone.0278009.s008">S7 File</xref>. Full explanations of other variables are available from the help function within the CellProfiler software or from the user manual on the CellProfiler website. For the development of OrganelleProfiler we used confocal images from 33 ECFC clones from several healthy donors. These ECFCs have previously been classified into separate phenotypic groups based on cellular morphology and showed clear differences in expression of cell surface markers, proliferation and storage and secretion of VWF [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>]. Representative images of 1 clone of group 1 (top) and 1 clone of group 3 (bottom) ECFCs used for this study are shown in <xref ref-type="fig" rid="pone.0278009.g001">Fig 1</xref>. The CellProfiler modules that together form the OrganelleProfiler pipeline can be divided into 6 steps (<xref ref-type="fig" rid="pone.0278009.g002">Fig 2</xref>), which are described below.</p>
<fig id="pone.0278009.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Representative images of healthy ECFC controls belonging to previously classified groups based on morphology [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>].</title>
<p>Group 1 ECFCs (top) and group 3 ECFCs (bottom) were stained with Hoechst (blue) and antibodies against VE-cadherin (red) and VWF (green). Scale bar represents 50 μm. Images were taken with a 63x objective.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g001" xlink:type="simple"/>
</fig>
<fig id="pone.0278009.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g002</object-id>
<label>Fig 2</label>
<caption>
<title>OrganelleProfiler: Quantitative and qualitative analysis of cells and cell secretory organelles.</title>
<p>Left, flowchart of the modules within the OrganelleProfiler pipeline. I) Input of images and splitting of channels. II) Smoothing (top), thresholding (middle) and identification of the nuclei (bottom). Every different color indicates a different object. III) Smoothing of the cell membrane (top), identification of the cells (middle) and identification of cell membranes (bottom) as objects. IV) VWF signal rescaling and enhancement (top) and identification of WPB objects (bottom). V) Relating WPBs and Cells as child and parent respectively. Same colored objects indicate a relationship to the same cell. VI) Generated output image overlaying the outline of the nuclei (blue), cells (red), and WPBs (green) objects on the VWF channel. With the addition of the cell number (purple).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g002" xlink:type="simple"/>
</fig>
<sec id="sec009">
<title>Step I—Input of images</title>
<p>Firstly, images of interest are imported into the software. In this example, 5 images from two groups of ECFCs were compared. Each image has 3 channels, 1 for the nuclei staining (Hoechst), one for cell membrane staining (VE-cadherin) and a third channel for organelle specific staining (VWF) (<xref ref-type="fig" rid="pone.0278009.g001">Fig 1</xref>). Channels are separated at this point so that each channel is processed separately in the following steps.</p>
</sec>
<sec id="sec010">
<title>Step II, III and IV—Identification of nuclei, cell membranes, cells and organelles</title>
<p>Second, the nuclei staining signal is smoothed and a threshold is applied for the identification of the nuclei as objects. This object, together with the smoothed cell membrane staining signal is used in step III for the identification of the whole cell as secondary object. The nuclei are used as a starting point from which the object propagates outward in all directions until it encounters a secondary signal, in this case the smoothed cell membrane. A third object is generated using the cell object. This third object consists of only the cell membrane which is needed in the OrgannelleContentPipeline. In parallel to steps II and III, step IV uses the organelle staining signal for identification of the organelles. The signal is first rescaled and the speckle and neurite features are enhanced, which yields a better separation of organelles if they are located close to, or on top of, each other. After modification, the organelles are identified as the fourth object class.</p>
</sec>
<sec id="sec011">
<title>Step V—Measurement and relating of objects</title>
<p>All objects that are generated in step II, III and IV are measured here. Size, shape and intensity, where relevant, is measured. Organelle objects are related to the nuclei and to the cell membrane in this step as well. This yields counts of secondary objects (organelles) per primary objects (cells) and distance of the secondary object to either the nuclei or the cell membrane. Measurements that we performed on the objects are eccentricity (as indicator for round or elongated WPB morphology), length of WPBs (maximum ferret diameter) and absolute as well as relative distance of WPBs to the nuclei and the cell membrane (<xref ref-type="fig" rid="pone.0278009.g003">Fig 3A</xref>).</p>
<fig id="pone.0278009.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Quantitative and morphological differences between ECFC control groups.</title>
<p>Two previously classified ECFCs based on morphology [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>], group 1 (green) and group 3 (red), were stained for Hoechst, VE-cadherin and VWF. Per control, 5 images were analyzed with the OrganelleProfiler pipeline (each 44100 μm<sup>2</sup> in size). A) Graphical representation of the measurements that were performed on the objects. Eccentricity (top), length of Weibel-Palade bodies (WPBs) measured as maximum ferret diameter (middle) and distance of WPBs to the nuclei and the cell membrane was measured (bottom). Relative distance of the WPB to the nucleus in the cell was calculated as 100% x (distance to nucleus) / (distance to nucleus + distance to cell membrane). B) Cell count per image. C) The cell area (μm<sup>2</sup>) per cell of all 5 images pooled (n = 188 in group 1 and n = 52 in group 3). D) Number of WPBs per cell. E) Distance of the WPB to the nucleus relative to their position in the cell in percentage. F) Mean WPB length per cell in μm. G) Mean eccentricity of WPBs per cell. Data is shown as median with min/max boxplot. Mann-Whitney U test was performed on not normally distributed data (D and G). Unpaired T test with Welch’s correction was performed on normally distributed data (B, C, E and F); *p&lt;0.05 **p&lt;0.01, ***p&lt;0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012">
<title>Step VI—Quality control and analysis of output</title>
<p>For quality control, all objects’ outlines are overlaid on the VWF signal. This overlay allows the user to check whether the pipeline was accurate in the identification of objects. Cells are numbered so potential outliers can be easily identified and the pipeline can be adjusted if needed. The exported output can be used to quantify and perform qualitative analysis on images of interest.</p>
<p>Automated quantification using OrganelleProfiler revealed significant differences in cell count, cell area and number, size, shape and localization of WPBs between group 1 and group 3 ECFCs (<xref ref-type="fig" rid="pone.0278009.g003">Fig 3B–3G</xref>). <xref ref-type="fig" rid="pone.0278009.g003">Fig 3B</xref> shows a significantly lower number of cells per image in group 3 (mean ± SD, 10.40 ± 2.40) compared to group 1 (37.60 ± 2.80) (p = 0.0003). Logically, as all ECFCs were confluent, we observed a larger mean cell area in group 3 (4016 ± 2445 μm<sup>2</sup>) than in group 1 (1143 ± 516.60 μm<sup>2</sup>) (<xref ref-type="fig" rid="pone.0278009.g003">Fig 3C</xref>) (p&lt;0.0001). The total number of WPBs per image was lower in group 1 compared to group 3 (not shown). Additionally, the number of WPBs per cell was significantly lower in group 3 (30.92 ± 29.54) than in group 1 (107.30 ± 58.51) (p&lt;0.0001) (<xref ref-type="fig" rid="pone.0278009.g003">Fig 3D</xref>). The distance of WPBs to the nuclei relative to their position in the cell was determined and shown in <xref ref-type="fig" rid="pone.0278009.g003">Fig 3E</xref>. The relative distance was significantly lower in group 3 ECFCs (32.31 ± 23.62%) when compared to group 1 (53 ± 30.10%) (p&lt;0.0001) indicating that within the cell, WPBs were located closer to the nucleus in group 3 ECFCs. Finally, the mean WPB length was lower in group 3 (1.10 ± 0.27 μm) versus (1.38 ± 0.21 μm) in group 1 ECFCs (p&lt;0.0001) and the WPBs were significantly more round in group 3 (0.63 ± 0.08)) versus (0.78 ± 0.04) (p&lt;0.0001) (<xref ref-type="fig" rid="pone.0278009.g003">Fig 3F and 3G</xref>). The lower number of WPBs and the observation that they are smaller and rounder in group 3 when compared to group 1 could explain the decreased production and secretion of VWF observed previously [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>].</p>
<p>To further validate the quantitative data obtained from our automated OrganelleProfiler pipeline we also performed a manual quantification of several of these parameters using Fiji image analysis software, specifically the region of interest manager [<xref ref-type="bibr" rid="pone.0278009.ref013">13</xref>]. One image of the group 1 ECFCs was used for the scoring. The manual scoring of the cells using the freehand selection resulted in 34 cells with a mean surface area of 1264 ± 497.93 μm<sup>2</sup>. For three cells all WPBs were scored by measuring the longest distance in the WPB using a straight line. In these cells the manual scoring showed a mean WPB count of 117 ± 38.63 and a length of 1.57 ± 0.09 μm. All measurements were compared with the CellProfiler measurements on the same image and none of the results differed significantly. Taken together, we can conclude that both measurements with CellProfiler and Fiji are comparable and thus CellProfiler can be used to accurately measure cells and organelles.</p>
</sec>
</sec>
<sec id="sec013">
<title>Validation and application of OrganelleProfiler</title>
<sec id="sec014">
<title>Identification of HEK293T cells and early endosomes</title>
<p>To demonstrate the versatility of the OrganelleProfiler pipeline, we extended our analyses to a different type of organelle (early endosome, visualized by staining for early endosome antigen 1, EEA1) and a different cell type (HEK293T). Representative images of ECFCs and HEK293T cells and the analyzed output of the OrganelleProfiler are shown in <xref ref-type="fig" rid="pone.0278009.g004">Fig 4A</xref>. The OrganelleProfiler was used to analyze three tile scans of each condition. <xref ref-type="fig" rid="pone.0278009.g004">Fig 4B</xref> shows significantly more HEK293T cells per image (1539 ± 82.71) than ECFCs (359.30 ± 4.16) (p = 0.0016) which were also smaller (397.8 ± 150 μm<sup>2</sup>) than ECFCs (1793 ± 866.3 μm<sup>2</sup>) (<xref ref-type="fig" rid="pone.0278009.g004">Fig 4C</xref>) (p&lt;0.0001). The number of early endosomes per cell was slightly lower in HEK293T cells (39.27 ± 16.22) compared to ECFCs (63.30 ± 41.02) (p&lt;0.0001) (<xref ref-type="fig" rid="pone.0278009.g004">Fig 4D</xref>). The relative distance of the early endosomes to the nuclei (<xref ref-type="fig" rid="pone.0278009.g004">Fig 4E</xref>) was higher in the HEK293T cells (45.34 ± 8.29%) when compared to ECFCs (40.05 ± 12.70%) (p&lt;0.0001). Finally, the mean early endosome eccentricity is slightly higher in HEK293T cells (0.59 ± 0.05) versus (0.58 ± 0.04) in ECFCs (p&lt;0.0001) (<xref ref-type="fig" rid="pone.0278009.g004">Fig 4F</xref>). Comparatively, the early endosomes are clearly rounder when compared to WPBs (0.78 ± 0.04, indicated by the red dotted line, data from <xref ref-type="fig" rid="pone.0278009.g003">Fig 3G</xref>) which are more elongated organelles.</p>
<fig id="pone.0278009.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Quantitative and morphological differences between early endosomes in ECFCs and HEK293T cells.</title>
<p>A) Representative images of ECFC (top) and HEK293T (bottom) cells where each panel shows the raw confocal image (left) and the identified object in Cellprofiler (right). Every different color indicates a different object. Cells were stained with DAPI (blue) and antibodies against β-catenin (red) and EEA1 (green). Scale bar represents 50 μm. Images were taken with a Leica Stellaris 5 LIA fitted with a 63x objective. Per cell type, 3 tile scans (each 754630 μm<sup>2</sup> in size) were analyzed with the OrganelleProfiler pipeline. B) Cell count per image. C) The cell area (μm<sup>2</sup>) per cell of all 3 tile scans pooled (n = 1078 ECFCs and n = 4618 HEK293T cells). D) Number of endosomes per cell. E) Mean relative distance of the endosome to the nucleus per cell. F) Mean eccentricity of endosomes per cell. Data is shown as median with min/max boxplot. Dashed red line represents mean eccentricity of WPBs as determined in <xref ref-type="fig" rid="pone.0278009.g003">Fig 3G</xref>. Mann-Whitney U test was performed on not normally distributed data (C,D,E,F). Unpaired T test with Welch’s correction was performed on normally distributed data (B); **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec015">
<title>WPB shortening after Golgi ribbon disruption and perinuclear clustering after stimulation</title>
<p>WPB length directly relates to the integrity of the Golgi ribbon: fragmented Golgi ribbons generate small WPBs while the longest WPBs require an extended, intact Golgi ribbon [<xref ref-type="bibr" rid="pone.0278009.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0278009.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0278009.ref016">16</xref>]. Pharmacological inhibition of microtubules using nocodazole can be used to unlink Golgi ribbons [<xref ref-type="bibr" rid="pone.0278009.ref017">17</xref>] and this has been shown to reduce the size of newly generated WPBs [<xref ref-type="bibr" rid="pone.0278009.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0278009.ref018">18</xref>]. We used OrganelleProfiler to quantify the reduction of WPB length in ECFCs that were treated for 46 hours with vehicle (DMSO, control) or 2 μg/ml nocodazole. Staining for VWF and the trans-Golgi network marker TGN46 revealed a clear disruption of the Golgi in nocodazole-treated cells (<xref ref-type="fig" rid="pone.0278009.g005">Fig 5A</xref>). The OrganelleProfiler was used to analyze three tile scans of each condition. Nocodazole exposure caused a lower cell count per image (<xref ref-type="fig" rid="pone.0278009.g005">Fig 5B</xref>) (n = 184.7 ± 5.51 versus n = 553 ± 36.43, p = 0.0027) with larger surface area (2859 ± 1314 μm<sup>2</sup>) than control ECFCs (1673 ± 641.6 μm<sup>2</sup>) (<xref ref-type="fig" rid="pone.0278009.g005">Fig 5C</xref>) (p&lt;0.0001). In the nocodazole treated cells we observed significantly rounder (nocodazole: 0.76 ± 0.06 vs control: 0.87 ± 0.02; p&lt;0.0001) and shorter WPBs (nocodazole: 1.17 μm ± 0.18 vs. control: 1.54 ± 0.17 μm; p&lt;0.0001) compared to the control cells (<xref ref-type="fig" rid="pone.0278009.g005">Fig 5D and 5E</xref>). The relative distance of the WPBs to the nuclei (<xref ref-type="fig" rid="pone.0278009.g005">Fig 5E</xref>) was slightly higher after nocodazole exposure (62.25 ± 13.77%) when compared to control (60.18 ± 8.17%) (p&lt;0.0018).</p>
<fig id="pone.0278009.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Microtubule disruption leads to Golgi fragmentation and smaller and rounder WPBs.</title>
<p>A) Representative images of ECFCs treated for 46 hours with vehicle (control, top) or 2 μg/ml nocodazole (bottom). Cells were stained with DAPI (blue) and antibodies against VE-cadherin (red), VWF (green) and TGN46 (magenta). Scale bar represents 50 μm and 20 μm in the zoom in. Images were taken with a 63x objective. Per cell type, 3 tile scans (each 936054 μm<sup>2</sup> in size) were analyzed with the OrganelleProfiler pipeline. B) Cell count per image. C) The cell area (μm<sup>2</sup>) per cell of all 3 tile scans pooled (n = 1659 in the control and n = 554 in the nocodazole treated cells). D) Mean eccentricity of WPBs per cell. E) Mean length (μm) of WPBs per cell F) Mean relative distance of the WPBs to the nucleus per cell. Data is shown as median with min/max boxplot. Mann-Whitney U test was performed on not normally distributed data (C,D,E,F). Unpaired T test with Welch’s correction was performed on normally distributed data (B); **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g005" xlink:type="simple"/>
</fig>
<p>It has previously been shown that, upon activation with cAMP-mediated agonists such as epinephrine or forskolin, endothelial cells cluster a subset of their WPBs at the microtubule organizing center (MTOC) via retrograde microtubular transport that depends on the minus-end motor protein dynein [<xref ref-type="bibr" rid="pone.0278009.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0278009.ref020">20</xref>]. We used OrganelleProfiler to quantify the reorganization of WPBs in forskolin-stimulated ECFCs (<xref ref-type="fig" rid="pone.0278009.g006">Fig 6A</xref>). Quantitative data gathered from one tile scan per condition shows that the per cell mean relative distance to the nucleus, which is directly adjacent to the MTOC and can therefore be used as a surrogate reference point for clustered WPBs, is lower in forskolin-treated cells (50.67 ± 14.76%, n = 352 cells) than in untreated cells (58.15 ± 10.22%, n = 537 cells) (<xref ref-type="fig" rid="pone.0278009.g006">Fig 6B</xref>, top). This indicates that in forskolin-treated cells, WPBs have on average moved towards the nucleus and thus into the direction of the MTOC. Also, when quantified on a single organelle basis, we see a shift towards lower relative distance to the nucleus in forskolin-treated cells (45.32 ± 31.39%, n = 17241 WPBs) compared with untreated cells (54.03 ± 30.77%, n = 21866 WPBs) (<xref ref-type="fig" rid="pone.0278009.g006">Fig 6B</xref>, bottom).</p>
<fig id="pone.0278009.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Perinuclear clustering of WPBs after cAMP-mediated signaling in ECFCs.</title>
<p>A) Representative images of ECFCs treated for 30 minutes with vehicle (control, top) or 10 uM Forskolin and 100 uM IBMX (F+I, bottom). Cells were stained with DAPI (blue) and antibodies against VE-cadherin (red) and VWF (green). Scale bar represents 50 μm and 20 μm in the zoom in. Images were taken with a 63x objective. Per condition, 1 tile scan (970221 μm<sup>2</sup> in size) was analyzed with the OrganelleProfiler pipeline. B) Mean relative distance of the WPBs to the nucleus per cell (top) (n = 537 in the control and n = 352 in the stimulated ECFCs) and per WPB (bottom) shown as violin plot (n = 21866 for the control and n = 17241 for the stimulated ECFCs). The black bar indicates the median with quartiles.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g006" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec016">
<title>OrganelleContentProfiler (OCP)—Automated measurement of proteins in secretory organelles</title>
<p>The OrganelleContentProfiler pipeline is an addition to the OrganelleProfiler pipeline. By adding 4 extra steps, secondary proteins of interest in, on or outside the organelle can be measured. For this purpose we analyzed the presence of Rab27A, a small GTPase that promotes WPB exocytosis and that is recruited to the WPB membrane during the maturation of these organelles after their separation from the Golgi complex [<xref ref-type="bibr" rid="pone.0278009.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0278009.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0278009.ref021">21</xref>]. We also determined, as a control, the presence of protein disulfide isomerase (PDI), a marker for the endoplasmic reticulum which should not show specific localization in or on the WPBs [<xref ref-type="bibr" rid="pone.0278009.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0278009.ref015">15</xref>]. <xref ref-type="fig" rid="pone.0278009.g007">Fig 7</xref> shows example images of Rab27A as well as PDI co-staining in group 1 healthy donor ECFCs that were used in this pipeline. The CellProfiler modules that together form the OrganelleContentProfiler pipeline can be divided into 4 steps (<xref ref-type="fig" rid="pone.0278009.g008">Fig 8</xref>), which are described below. Further details on every module are described in <xref ref-type="supplementary-material" rid="pone.0278009.s008">S7 File</xref>.</p>
<fig id="pone.0278009.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Representative images of one healthy group 1 ECFC control belonging to previously classified groups based on morphology [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>].</title>
<p>Cells were stained for Hoechst (blue), VE-cadherin (red), VWF (green) and Rab27A (top) or PDI (bottom). Scale bar represents 20 μm. Images were taken with a 63x objective. Red arrows indicate WPBs as identified in the VWF channel and the same location in the Rab27A or PDI channel.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g007" xlink:type="simple"/>
</fig>
<fig id="pone.0278009.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g008</object-id>
<label>Fig 8</label>
<caption>
<title>OrganelleContentProfiler: Quantitative and qualitative analysis of other organelle proteins.</title>
<p>Top, flowchart of the modules within the OrganelleContentProfiler pipeline. I) Input of Rab27A (Organelle content) channel and rescaling of this channel. II) Input of primary object (Organelle) (left) and expansion of this object (right). III) Masking of the Rab27A channel using the Expanded organelle objects to leave only Rab27A signal inside the organelle (left). Identification of the Rab27A signal per WPB as object (middle) and relating these objects to the cells as child and parent respectively (right). IV) Masking of the Rab27A channel using the Expanded organelle objects to leave only Rab27A signal outside the organelle (left). Identification of the Rab27A signal in the cell as object without the WPBs (middle) and relating these objects to the cells as child and parent respectively (right). * Identified in step IV of the OrganelleProfiler pipeline (<xref ref-type="fig" rid="pone.0278009.g002">Fig 2</xref>). ** Pipeline continues with step V and VI from the OrganelleProfiler pipeline.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g008" xlink:type="simple"/>
</fig>
<sec id="sec017">
<title>Step I—Input of an additional channel</title>
<p>Similarly to the OrganelleProfiler, images are imported into the software. In this example, images have one additional channel containing the staining for either Rab27A or PDI. Again, channels are separated and the fourth channel is rescaled in order to view the channel in the final quality control.</p>
</sec>
<sec id="sec018">
<title>Step II—Import of organelle object identified in the OrganelleProfiler pipeline</title>
<p>In this step, the organelle object as identified in the OrganelleProfiler pipeline is modified. The objects are initially identified using the staining for VWF, which is a cargo protein that is contained within the organelle. The secondary protein of interest, Rab27A, is a membrane protein that is located on the cytoplasmic face of the WPB membrane. To ensure full encapsulation of the Rab27A signal the object is therefore expanded by 2 pixels in all directions.</p>
</sec>
<sec id="sec019">
<title>Step III and IV—Identification of the secondary protein of interest “inside” and outside the organelle</title>
<p>In these parallel steps, the expanded organelle objects and the rescaled secondary staining channel are used. The expanded objects are used as a mask to remove all signal of the Rab27A or PDI staining outside the organelle (step III) and inside the organelle (step IV). The remaining signal is then identified as object, resulting in two new objects containing the signal inside the organelles and outside the organelles respectively. These new objects are processed according to step V from the OrganelleProfiler including the measurements, relating, quality control and export.</p>
</sec>
<sec id="sec020">
<title>Step V and VI—Measurements, quality control and analysis of results</title>
<p>In the OrganelleContentProfiler pipeline, different stainings on the same ECFC control are compared. In addition to the output from the OrganelleProfiler, the OrganelleContentProfiler provides measurements of the intensity of a secondary signal inside the organelle. Furthermore, it can quantify the cytoplasmic intensity values outside of the organelle which can be used for correction of the “inside” organelle signal. Signal intensity is noted as arbitrary intensity units (A.U.) as microscopes are not calibrated to an absolute scale.</p>
<p>We first confirmed that the number of WPBs quantified using OrganelleContentProfiler does not depend on the co-staining used (Rab27A: 204.8 ± 70.48; PDI: 146, ± 56.38; p = 0.24) (<xref ref-type="fig" rid="pone.0278009.g009">Fig 9A</xref>). ECFCs were stained with Hoechst and with antibodies against VE-cadherin, VWF and Rab27A or PDI. <xref ref-type="fig" rid="pone.0278009.g009">Fig 9B</xref> shows the A.U. inside and outside organelles and the A.U. inside the organelle corrected for the outside value. First, the VWF A.U. was analyzed as a measurement of a protein that is located predominantly in the WPB. The results show that the VWF A.U. values outside the WPBs was nearly zero (0.00076 ± 0.00033) and differed significantly from the inside A.U. (0.028 ± 0.0040) (p = 0.0016) indicating that VWF is almost exclusively present in WPBs. Secondly, it was determined that the Rab27A staining shows a significantly higher A.U. inside (0.081 ± 0.0085) the WPBs when compared to the outside measurement (0.052 ± 0.0041) (p = 0.0062). From this it can be concluded that part of the Rab27A protein is present in or on the WPB. Finally, the A.U. of the PDI staining was analyzed. PDI is only present inside the endoplasmic reticulum and should not yield increased A.U. inside the WPB. Indeed, the A.U. inside (0.074 ± 0.016) and outside (0.062 ± 0.0082) the organelle were similar (p = 0.20), indicating that PDI is not located specifically in or on WPBs.</p>
<fig id="pone.0278009.g009" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0278009.g009</object-id>
<label>Fig 9</label>
<caption>
<title>Quantification of signal intensity inside cell organells.</title>
<p>A group 1 ECFC control as defined previously [<xref ref-type="bibr" rid="pone.0278009.ref006">6</xref>] was stained with Hoechst and with antibodies against VE-cadherin, VWF and PDI or Rab27A. One image (12769 μm<sup>2</sup>) per staining was analyzed using the OrganelleContentProfiler pipeline. A) Both images had the same number of cells (n = 4) and roughly the same number of WPBs. B) the mean intensity in arbitrary intensity units (A.U.) per cell for the PDI (left), Rab27A (middle) and VWF (right) staining. Each graph shows the measured mean intensity inside (in) the WPBs, outside (out) the WPBs and the intensity inside the WPB after correcting for the out signal (corr). Data is shown as median with min/max boxplot. RM one way ANOVA was performed with Geisser-Greenhouse correction; *p&lt;0.05 **p&lt;0.01, ***p&lt;0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.g009" xlink:type="simple"/>
</fig>
<p>Once more, to validate the quantitative data obtained by CellProfiler, we also performed a manual scoring using Fiji for the A.U. of the Rab27A and VWF staining inside and outside of all WPBs (n = 199) in one cell. We observed that the results determined manually using Fiji (A.U. VWF inside = 0.039, VWF outside = 0.000029; Rab27A inside = 0.094, Rab27A outside = 0.053) lie within the same range as those determined by CellProfiler. This shows that the OrganelleContentProfiler can determine organelle specific stainings and measure the intensity of the staining corrected for the cytoplasmic value.</p>
</sec>
</sec>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Discussion</title>
<p>Quantifying large numbers of organelles is challenging due to the density and morphological heterogeneity of the organelles. The pipelines described here can be used to overcome these challenges and can provide organelle analysis in great detail on a larger scale. The OrganelleProfiler allows for measurement of cell and nucleus quantity and shape, and organelle quantity, shape, size and location within the cell. The organelles are also related to the cells which allows for cell-by-cell analysis. This information can be used to determine differences between a heterogeneous cell population or between patient and control cells. The OrganelleProfiler pipeline has shown significant differences between group 1 and group 3 ECFC controls based on only 5 images. Moreover, we were able to quantitatively determine differences in WPB length upon treatment with cytoskeletal drugs and differences in intracellular localization after induction of retrograde transport of WPBs. Once optimized for a set of images, the pipeline can analyze thousands of cells and hundreds of thousands of organelles within hours without potential bias associated with manual image processing and quantification. As shown with the early endosome staining, it is possible to adjust the pipeline to quantify other cell types and organelles. The pipeline was able to quantify differences between ECFCs and HEK293T cells and showed clear differences in eccentricity of the elongated WPBs compared to the round early endosomes.</p>
<p>With the OrganelleContentProfiler, secondary organelle markers can be measured and quantified. We showed 3 stainings of proteins with different localizations; PDI, which is only present on the endoplasmic reticulum, Rab27A which is present in the cytoplasm, but is also trafficked to the WPBs, and VWF which is mostly present in WPBs. Using the OrganelleContentProfiler pipeline we were able to quantify these stainings and determine the localization of these proteins. It is also possible to measure other organelle stainings at the same time by duplicating modules 3 to 8 of this pipeline and adjusting these for the additional channels.</p>
<p>Finetuning of the smoothing, thresholds and enhancement of the signal is necessary to ensure correct identification of objects. For every image set, a balance must be found to prevent over and under segmentation of organelles. Despite optimization, perfect segmentation of organelles is not always possible, especially in areas where organelles are crowded together. These imperfections may lead to incorrect identification of organelles, which could play out as underestimations of WPB numbers or overestimation of WPB dimensions. However, as all images are analyzed by the same pipeline, this error is expected to occur to a similar extent in all samples. One point of improvement on the OrganelleContentProfiler pipeline could be the correction of the organelle secondary staining with the intensity levels directly surrounding the organelle instead of the mean intensity in the entire cytoplasm. This was not possible within the CellProfiler software but could be done in data processing afterwards using the MeasureObjectIntensityDistribution module and relating this to the distance of WPBs to the nucleus [<xref ref-type="bibr" rid="pone.0278009.ref007">7</xref>].</p>
<p>A comparison with manual scoring using Fiji was performed to check the validity of the results generated by our automated pipelines. We generally found that the results obtained with OrganelleProfiler and OrganelleContentProfiler correspond very well with manual quantifications using Fiji, although subtle differences were found for two parameters. First, the maximum ferret diameter is calculated based on the smallest convex hull that is created around the WPB. The manual scoring measured the length of the WPB in a line and not as the inside of a convex hull. This could cause the slight difference in length as measured between CellProfiler and Fiji. Second, VWF and Rab27A intensities inside WPBs as determined by manual scoring was slightly higher than from the OrganelleContentProfiler measurements. Possibly, the outlines that were drawn around WPBs manually were more strict than those generated by OrganelleContentProfiler, because the human eye is less capable at detecting the very small changes in signal intensity near the edges of the organelles. As such, the signal intensities in these edges may have not been included in the manual analysis, resulting in a higher mean value per WPB.</p>
<p>To conclude, the OrganelleProfiler and OrganelleContentProfiler pipelines provide powerful, high-processing quantitative tools for analysis of cell and organelle count, size, shape, location and content. These pipelines were created with the purpose of analyzing morphometric parameters of WPBs in endothelial cells, but as shown for the HEK293T cells and early endosomes, they can be easily adjusted for use on different cell types or organelles. This can be especially useful for analysis of large datasets where manual quantification of organelle parameters would be unfeasible.</p>
</sec>
<sec id="sec022" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="pone.0278009.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Supporting information on antibodies.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0278009.s002" mimetype="application/octet-stream" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s002" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>OrganelleProfiler pipeline.</title>
<p>(CPPIPE)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0278009.s003" mimetype="application/octet-stream" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s003" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>OrganelleContentProfiler pipeline.</title>
<p>(CPPIPE)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0278009.s004" mimetype="application/octet-stream" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s004" xlink:type="simple">
<label>S3 File</label>
<caption>
<title>OrganelleProfiler pipeline (adjusted and optimized for use on endosomes in HEK293T cells).</title>
<p>(CPPIPE)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0278009.s005" mimetype="application/octet-stream" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s005" xlink:type="simple">
<label>S4 File</label>
<caption>
<title>OrganelleProfiler pipeline (adjusted and optimized for use on endosomes in ECFCs).</title>
<p>(CPPIPE)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0278009.s006" mimetype="application/octet-stream" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s006" xlink:type="simple">
<label>S5 File</label>
<caption>
<title>OrganelleProfiler pipeline (adjusted and optimized for samples exposed to nocodazole).</title>
<p>(CPPIPE)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0278009.s007" mimetype="application/octet-stream" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s007" xlink:type="simple">
<label>S6 File</label>
<caption>
<title>OrganelleProfiler pipeline (adjusted and optimized for samples exposed to forskolin).</title>
<p>(CPPIPE)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0278009.s008" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s008" xlink:type="simple">
<label>S7 File</label>
<caption>
<title>Detailed guide per module of the OP and OCP pipelines.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The SYMPHONY consortium, which aims to orchestrate personalized treatment in patients with bleeding disorders, is a unique collaboration between patients, health care professionals, and translational and fundamental researchers specializing in inherited bleeding disorders, as well as experts from multiple disciplines [<xref ref-type="bibr" rid="pone.0278009.ref022">22</xref>]. It aims to identify best treatment choice for each individual based on bleeding phenotype. To achieve this goal, work packages (WP) have been organized according to 3 themes (e.g. Diagnostics [WPs 3 and 4], Treatment [WPs 5–9], and Fundamental Research [WPs 10–12]). Principal investigator: M.H. Cnossen; project manager: S.H. Reitsma.</p>
<p>According to Theme and workpackage: Prof. dr. M. de Haas, Dr. M. van den Biggelaar, Sanquin, Prof. dr. M.P.M de Maat, R.A. Arisz, Erasmus MC, Prof. dr. R.E.G. Schutgens, Dr. R.T. Urbanus, M. Zivkovic, UMCU, Prof. dr. F.W.G. Leebeek, Prof. Dr. H.F. Lingsma, E.S. van Hoorn, Erasmus MC, Prof. dr. R.A.A. Mathot, L.H. Bukkems, M.E. Cloesmeijer, A. Janssen, S.F. Koopman, Amsterdam UMC, M.C.H.J. Goedhart, L.G.R. Romano, W. Al Arashi, C. Mussert, Erasmus MC, Dr. S.C. Gouw, M.R. Brands, Amsterdam UMC, R.M.T. ten Ham, UMCU, D.M. Prameyllawati, Erasmus MC, Prof. dr. K. Meijer, UMCG, Prof. dr. A.L. Bredenoord, EUR, Dr. R. van der Graaf, L. Baas, UMCU, Prof. dr. J.J. Voorberg, Sanquin, Prof. dr. K. Fijnvandraat, Amsterdam UMC, Prof. dr. A.B. Meijer, J. Del Castillo Alferes, Dr. E. van den Akker, H. Zhang, Sanquin, Dr. R. Bierings, Erasmus MC, Prof dr. H.C.J. Eikenboom, LUMC, Dr. I. van Moort, Erasmus MC, S.N.J. Laan, LUMC.</p>
<p>Advisory Board: Prof. dr. C.A. Uyl-de Groot (EUR), C. Smit, G. Wijfjes (NVHP), Dr. M.H.A. Bos (NVTH), Prof. dr. V.W.V. Jaddoe (Erasmus MC), Prof. dr. P.J. Lenting (Université Paris-Saclay), Prof. dr. M. Makris (University of Sheffield), Prof. dr. Y.M.C. Henskens (MUMC).</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>A.U.</term>
<def><p>Arbitrary intensity units</p></def>
</def-item>
<def-item><term>ECFC</term>
<def><p>Endothelial colony forming cell</p></def>
</def-item>
<def-item><term>HEK293T</term>
<def><p>Human embryonic kidney 293T</p></def>
</def-item>
<def-item><term>MTOC</term>
<def><p>Microtubule organizing center</p></def>
</def-item>
<def-item><term>OCP</term>
<def><p>OrganelleContentProfiler</p></def>
</def-item>
<def-item><term>OP</term>
<def><p>OrganelleProfiler</p></def>
</def-item>
<def-item><term>PDI</term>
<def><p>Protein disulfide isomerase</p></def>
</def-item>
<def-item><term>VWD</term>
<def><p>Von Willebrand disease</p></def>
</def-item>
<def-item><term>VWF</term>
<def><p>Von Willebrand factor</p></def>
</def-item>
<def-item><term>WPB</term>
<def><p>Weibel-Palade body</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pone.0278009.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schillemans</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Karampini</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bierings</surname> <given-names>R</given-names></name>. <article-title>Exocytosis of Weibel-Palade bodies: how to unpack a vascular emergency kit</article-title>. <source>J Thromb Haemost</source>. <year>2019</year>;<volume>17</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>18</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jth.14322" xlink:type="simple">10.1111/jth.14322</ext-link></comment> <object-id pub-id-type="pmid">30375718</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Valentijn</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Sadler</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Valentijn</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Voorberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Eikenboom</surname> <given-names>J</given-names></name>. <article-title>Functional architecture of Weibel-Palade bodies</article-title>. <source>Blood</source>. <year>2011</year>;<volume>117</volume>(<issue>19</issue>):<fpage>5033</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2010-09-267492" xlink:type="simple">10.1182/blood-2010-09-267492</ext-link></comment> <object-id pub-id-type="pmid">21266719</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Margadant</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Voorberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bierings</surname> <given-names>R</given-names></name>. <article-title>Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response</article-title>. <source>FEBS J</source>. <year>2022</year>;<volume>289</volume>(<issue>22</issue>):<fpage>6863</fpage>–<lpage>6870</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/febs.16421" xlink:type="simple">10.1111/febs.16421</ext-link></comment> <object-id pub-id-type="pmid">35246944</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Valentijn</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Eikenboom</surname> <given-names>J</given-names></name>. <article-title>Weibel-Palade bodies: a window to von Willebrand disease</article-title>. <source>J Thromb Haemost</source>. <year>2013</year>;<volume>11</volume>(<issue>4</issue>):<fpage>581</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jth.12160" xlink:type="simple">10.1111/jth.12160</ext-link></comment> <object-id pub-id-type="pmid">23398618</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Jong</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Weijers</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Dirven</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>de Boer</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Streur</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Eikenboom</surname> <given-names>J</given-names></name>. <article-title>Variability of von Willebrand factor-related parameters in endothelial colony forming cells</article-title>. <source>J Thromb Haemost</source>. <year>2019</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1544</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jth.14558" xlink:type="simple">10.1111/jth.14558</ext-link></comment> <object-id pub-id-type="pmid">31265169</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Boer</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bowman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Notley</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lima</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>de Jong</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease</article-title>. <source>J Thromb Haemost</source>. <year>2020</year>;<volume>18</volume>(<issue>10</issue>):<fpage>2721</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jth.14998" xlink:type="simple">10.1111/jth.14998</ext-link></comment> <object-id pub-id-type="pmid">32654420</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stirling</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Swain-Bowden</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Lucas</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Carpenter</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Cimini</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Goodman</surname> <given-names>A</given-names></name>. <article-title>CellProfiler 4: improvements in speed, utility and usability</article-title>. <source>BMC Bioinformatics</source>. <year>2021</year>;<volume>22</volume>(<issue>1</issue>):<fpage>433</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12859-021-04344-9" xlink:type="simple">10.1186/s12859-021-04344-9</ext-link></comment> <object-id pub-id-type="pmid">34507520</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hannah</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Hume</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Arribas</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hewlett</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Seabra</surname> <given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>Weibel-Palade bodies recruit Rab27 by a content-driven, maturation-dependent mechanism that is independent of cell type</article-title>. <source>J Cell Sci</source>. <year>2003</year>;<volume>116</volume>(<issue>Pt 19</issue>):<fpage>3939</fpage>–<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jcs.00711" xlink:type="simple">10.1242/jcs.00711</ext-link></comment> <object-id pub-id-type="pmid">12928333</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bierings</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hellen</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kiskin</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Knipe</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Fonseca</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Patel</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>The interplay between the Rab27A effectors Slp4-a and MyRIP controls hormone-evoked Weibel-Palade body exocytosis</article-title>. <source>Blood</source>. <year>2012</year>;<volume>120</volume>(<issue>13</issue>):<fpage>2757</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2012-05-429936" xlink:type="simple">10.1182/blood-2012-05-429936</ext-link></comment> <object-id pub-id-type="pmid">22898601</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bürgisser</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Janssen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>De Cuyper</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Conte</surname> <given-names>IL</given-names></name>, <name name-style="western"><surname>Hume</surname> <given-names>AN</given-names></name>, <etal>et al</etal>. <article-title>GDP/GTP exchange factor MADD drives activation and recruitment of secretory Rab GTPases to Weibel-Palade bodies</article-title>. <source>Blood Adv</source>. <year>2021</year>;<volume>5</volume>(<issue>23</issue>):<fpage>5116</fpage>–<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/bloodadvances.2021004827" xlink:type="simple">10.1182/bloodadvances.2021004827</ext-link></comment> <object-id pub-id-type="pmid">34551092</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schillemans</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Westeneng</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gangaev</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hofman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nota</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Alternative trafficking of Weibel-Palade body proteins in CRISPR/Cas9-engineered von Willebrand factor-deficient blood outgrowth endothelial cells</article-title>. <source>Res Pract Thromb Haemost</source>. <year>2019</year>;<volume>3</volume>(<issue>4</issue>):<fpage>718</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/rth2.12242" xlink:type="simple">10.1002/rth2.12242</ext-link></comment> <object-id pub-id-type="pmid">31624792</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Hooren</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>van Breevoort</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Fernandez-Borja</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Meijer</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Eikenboom</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bierings</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 regulates epinephrine-induced exocytosis of Weibel-Palade bodies</article-title>. <source>J Thromb Haemost</source>. <year>2014</year>;<volume>12</volume>(<issue>2</issue>):<fpage>273</fpage>–<lpage>81</lpage>.</mixed-citation></ref>
<ref id="pone.0278009.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schindelin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Arganda-Carreras</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Frise</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kaynig</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Longair</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pietzsch</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Fiji: an open-source platform for biological-image analysis</article-title>. <source>Nature Methods</source>. <year>2012</year>;<volume>9</volume>(<issue>7</issue>):<fpage>676</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth.2019" xlink:type="simple">10.1038/nmeth.2019</ext-link></comment> <object-id pub-id-type="pmid">22743772</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferraro</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kriston-Vizi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Metcalf</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Martin-Martin</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Freeman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Burden</surname> <given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>A two-tier Golgi-based control of organelle size underpins the functional plasticity of endothelial cells</article-title>. <source>Dev Cell</source>. <year>2014</year>;<volume>29</volume>(<issue>3</issue>):<fpage>292</fpage>–<lpage>304</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.devcel.2014.03.021" xlink:type="simple">10.1016/j.devcel.2014.03.021</ext-link></comment> <object-id pub-id-type="pmid">24794632</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Karampini</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hoogendijk</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Bürgisser</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Mulder</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Van Alphen</surname> <given-names>FPJ</given-names></name>, <etal>et al</etal>. <article-title>Syntaxin 5 determines Weibel-Palade body size and von Willebrand factor secretion by controlling Golgi architecture</article-title>. <source>Haematologica</source>. <year>2022</year>;<volume>107</volume>(<issue>8</issue>):<fpage>1827</fpage>–<lpage>39</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3324/haematol.2021.280121" xlink:type="simple">10.3324/haematol.2021.280121</ext-link></comment> <object-id pub-id-type="pmid">35081689</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karampini</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bürgisser</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Olins</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mulder</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Jost</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Geerts</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Sec22b determines Weibel-Palade body length by controlling anterograde ER-Golgi transport</article-title>. <source>Haematologica</source>. <year>2021</year>;<volume>106</volume>(<issue>4</issue>):<fpage>1138</fpage>–<lpage>47</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3324/haematol.2019.242727" xlink:type="simple">10.3324/haematol.2019.242727</ext-link></comment> <object-id pub-id-type="pmid">32336681</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thyberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Moskalewski</surname> <given-names>S</given-names></name>. <article-title>Microtubules and the organization of the Golgi complex</article-title>. <source>Exp Cell Res</source>. <year>1985</year>;<volume>159</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0014-4827%2885%2980032-x" xlink:type="simple">10.1016/s0014-4827(85)80032-x</ext-link></comment> <object-id pub-id-type="pmid">3896822</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferraro</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Patella</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Costa</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Ketteler</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kriston-Vizi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cutler</surname> <given-names>DF</given-names></name>. <article-title>Modulation of endothelial organelle size as an antithrombotic strategy</article-title>. <source>Journal of Thrombosis and Haemostasis</source>. <year>2020</year>;<volume>18</volume>(<issue>12</issue>):<fpage>3296</fpage>–<lpage>308</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jth.15084" xlink:type="simple">10.1111/jth.15084</ext-link></comment> <object-id pub-id-type="pmid">32881285</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rondaij</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Bierings</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kragt</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gijzen</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Sellink</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>van Mourik</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Dynein-dynactin complex mediates protein kinase A-dependent clustering of Weibel-Palade bodies in endothelial cells</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2006</year>;<volume>26</volume>(<issue>1</issue>):<fpage>49</fpage>–<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.ATV.0000191639.08082.04" xlink:type="simple">10.1161/01.ATV.0000191639.08082.04</ext-link></comment> <object-id pub-id-type="pmid">16239597</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Agtmaal</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Bierings</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Dragt</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Leyen</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Fernandez-Borja</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Horrevoets</surname> <given-names>AJG</given-names></name>, <etal>et al</etal>. <article-title>The Shear Stress-Induced Transcription Factor KLF2 Affects Dynamics and Angiopoietin-2 Content of Weibel-Palade Bodies</article-title>. <source>PLOS ONE</source>. <year>2012</year>;<volume>7</volume>(<issue>6</issue>):<fpage>e38399</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0038399" xlink:type="simple">10.1371/journal.pone.0038399</ext-link></comment> <object-id pub-id-type="pmid">22715381</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zografou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Basagiannis</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Papafotika</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Shirakawa</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Horiuchi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Auerbach</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>A complete Rab screening reveals novel insights in Weibel-Palade body exocytosis</article-title>. <source>J Cell Sci</source>. <year>2012</year>;<volume>125</volume>(<issue>Pt 20</issue>):<fpage>4780</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jcs.104174" xlink:type="simple">10.1242/jcs.104174</ext-link></comment> <object-id pub-id-type="pmid">22899725</object-id></mixed-citation></ref>
<ref id="pone.0278009.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cnossen</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>van Moort</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>de Maat</surname> <given-names>MPM</given-names></name>, <name name-style="western"><surname>Schutgens</surname> <given-names>REG</given-names></name>, <name name-style="western"><surname>Urbanus</surname> <given-names>RT</given-names></name>, <etal>et al</etal>. <article-title>SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders</article-title>. <source>J Thromb Haemost</source>. <year>2022</year>;<volume>20</volume>(<issue>9</issue>):<fpage>2001</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jth.15778" xlink:type="simple">10.1111/jth.15778</ext-link></comment> <object-id pub-id-type="pmid">35652368</object-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article article-type="aggregated-review-documents" id="pone.0278009.r001" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0278009.r001</article-id>
<title-group>
<article-title>Decision Letter 0</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Alfonso</surname>
<given-names>Julieta</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2023</copyright-year>
<copyright-holder>Julieta Alfonso</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0278009" document-id-type="doi" document-type="article" id="rel-obj001" link-type="peer-reviewed-article"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>0</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">2 Jan 2023</named-content>
</p>
<p><!-- <div> -->PONE-D-22-30713<!-- </div> --><!-- <div> -->Automated segmentation and quantitative analysis of organelle morphology, localization and content using CellProfiler<!-- </div> --><!-- <div> -->PLOS ONE<!-- </div> --></p>
<p>Dear Dr. <!-- <span id="lblTo"> -->Ruben Bierings,<!-- </span> --></p>
<p><!-- <div> -->Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>We have received one review of your paper from an external reviewer, and to speed up the process I have acted both as Academic Editor and as a Reviewer.</p>
<p>As you will see, the assessment of your study is in general positive but there are a number of issues that should be addressed before the paper is suitable for publication in PLOS ONE.</p>
<p>Please submit your revised manuscript by Feb 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email xlink:type="simple">plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pone/" xlink:type="simple">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:<list list-type="bullet"> <list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item> <list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item> <list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" xlink:type="simple">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link ext-link-type="uri" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" xlink:type="simple">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Julieta Alfonso, Ph.D.</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at </p>
<p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" xlink:type="simple">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" xlink:type="simple">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p>
<p>Additional Editor Comments:</p>
<p>Review from Editor:</p>
<p>Laan et al. propose a method to automatically assess the number, morphology, and localization of intracellular organelles. To test the validity of the method, the authors used as a model endothelial forming cells that contain secretory organelles known as Weibel-Palade bodies.</p>
<p>The manuscript is well-written and contains valuable information for the cell biology community. However, the study focuses on one specific cellular model, which might limit the interest to a rather small scientific community. The authors claim that CellProfiler could be used for a variety of cell types and organelles. I encourage the authors to include yet another model for their analysis to validate the method in a wider range of cellular systems.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p><!-- <font color="black"> --><bold>Comments to the Author</bold></p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. <!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->2. Has the statistical analysis been performed appropriately and rigorously? <!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <ext-link ext-link-type="uri" xlink:href="http://www.plosone.org/static/policies.action#sharing" xlink:type="simple">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.<!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->5. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
<p>Reviewer #1: In this manuscript Laan et al. have very elegantly described an automated method for the quantification of several parameter including length, distance from nucleus/ cell membrane, of subcellular organelles known as Weibel-Palade bodies (WPBs) in endothelial cells. This pipeline can be proven very useful in the production of unbiased data with morphometric charasterics of intracellular organelles including WPBs. Although the manuscript is very well written and sound, there are points in the manuscript that can be improved.</p>
<p>1. It is not very well explained how many ECFCs cell lines were used to develop this pipeline. Additionally, there is need for more clarification in how many images were used to create the pipeline and how many images the pipeline was tested onto. Could the authors provide this information?</p>
<p>2. Although Rab27a is a well known marker for mature WPBs, in the images shown there is also a lot of background that can skew their analysis. Do the authors have an explanation for that and also a different antibody to test. Another marker is CD63 that it have been shown to localize not only on lysosomes but also on WPBs. It would be very interesting to show this staining to as previous research has indicated CD63 to be not only localized in/ on WPBs but also in vesicles in WPBs. Can this pipeline distinguish these localizations?</p>
<p>3. Although the 2 groupd of ECFCs are clearly different in their morphology and content, which provides more evidence on the heterogeneity of ECFCs it would be interesting to show that the pipeline can distinguish the morphological parameters after treatment of eg group 1 ECFCs with nocodazole that disrupts the Golgi ribbon and results in shorter WPBs.</p>
<p>4. As the authors showed that the pipeline can very nicely indicate the distance of the organelle to the nucleus and cell membrane, it would be very interesting to show the distance to the nucleus and cell membrane after activation of ECFCs with different stimuli. The authors have previously shown very nicely that for example cAMP signaling can induce WPB perinuclear clustring. Does the pipeline can make these distinctions?</p>
<p>There are also 2 minor comments:</p>
<p>1. It is not shown on the graphs how many points there are per bar. When there are very big data sets even small differences can be statistically significant even though there is a minor change (eg length of the WPBs between group 1 and 3).</p>
<p>2. The authors showed there are less cells per field of view between gorup 1 and 3 with group 3 cells being significantly larger in cell area. Does correction for the larger cell area normalizes the cell count per field of view?</p>
<p>**********</p>
<p><!-- <font color="black"> -->6. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" xlink:type="simple">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy" xlink:type="simple">Privacy Policy</ext-link>.<!-- </font> --></p>
<p>Reviewer #1: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/" xlink:type="simple">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email xlink:type="simple">figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
</body>
</sub-article>
<sub-article article-type="author-comment" id="pone.0278009.r002">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0278009.r002</article-id>
<title-group>
<article-title>Author response to Decision Letter 0</article-title>
</title-group>
<related-object document-id="10.1371/journal.pone.0278009" document-id-type="doi" document-type="peer-reviewed-article" id="rel-obj002" link-type="rebutted-decision-letter" object-id="10.1371/journal.pone.0278009.r001" object-id-type="doi" object-type="decision-letter"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="author-response-date">28 Apr 2023</named-content>
</p>
<p>Dear sir/madam,</p>
<p>Below you can find our responses to each comment of the editor and reviewer. This information has also been added as the "Response to Reviewers" file.</p>
<p>Response to the editor and reviewer: 28-04-2023</p>
<p>We thank you for the feedback on our manuscript. The detailed comments were helpful and we believe they improved the clarity and impact of our study. Below we address the comments from the reviewers. We hope that the revised work meets the standards for publication. Our responses are noted in bold below the original comment/question. In the manuscript changes or additions are indicated in red.</p>
<p>Editor:</p>
<p>Laan et al. propose a method to automatically assess the number, morphology, and localization of intracellular organelles. To test the validity of the method, the authors used as a model endothelial forming cells that contain secretory organelles known as Weibel-Palade bodies.</p>
<p>The manuscript is well-written and contains valuable information for the cell biology community. However, the study focuses on one specific cellular model, which might limit the interest to a rather small scientific community. The authors claim that CellProfiler could be used for a variety of cell types and organelles. I encourage the authors to include yet another model for their analysis to validate the method in a wider range of cellular systems.</p>
<p>answer to editor:</p>
<p>We appreciate the positive comments and agree with the reviewer that the study's focus on one specific cellular model may limit its interest to a relatively small scientific community. Therefore, we have included a second cell model (HEK293T cells) and a different organelle (early endosomes stained with EEA1) in our analysis (figure 4). Our data shows that the OrganelleProfiler pipeline can accurately identify endosomes in both ECFCs and in HEK293T cells. Furthermore, with only minor adjustments the pipeline was optimized to accurately delineate individual HEK293T cells which, contrary to ECFCs do not form fully confluent monolayers. By doing so, we were able to validate the method in a wider range of cellular systems and demonstrate its versatility. Further details and data are noted in the manuscript. </p>
<p> </p>
<p>Reviewer #1: </p>
<p>In this manuscript Laan et al. have very elegantly described an automated method for the quantification of several parameter including length, distance from nucleus/ cell membrane, of subcellular organelles known as Weibel-Palade bodies (WPBs) in endothelial cells. This pipeline can be proven very useful in the production of unbiased data with morphometric characteristics of intracellular organelles including WPBs. Although the manuscript is very well written and sound, there are points in the manuscript that can be improved.</p>
<p>answer to reviewer #1:</p>
<p>Thank you for your detailed review of our manuscript. We appreciate your comments and suggestions for improvement. Please find our responses to your questions below:</p>
<p>1. It is not very well explained how many ECFCs cell lines were used to develop this pipeline. Additionally, there is need for more clarification in how many images were used to create the pipeline and how many images the pipeline was tested onto. Could the authors provide this information?</p>
<p>answer 1:</p>
<p>We agree that information on the number of ECFC cell lines and images used to develop and test our pipeline was unclear. The pipeline was developed using a large group of 33 ECFC clones. The pipeline was then tested on 5 tile scans from 1 clone per group. This information is now adjusted/ added in the methods of the manuscript. </p>
<p>2. Although Rab27a is a well-known marker for mature WPBs, in the images shown there is also a lot of background that can skew their analysis. Do the authors have an explanation for that and also a different antibody to test. Another marker is CD63 that it have been shown to localize not only on lysosomes but also on WPBs. It would be very interesting to show this staining to as previous research has indicated CD63 to be not only localized in/ on WPBs but also in vesicles in WPBs. Can this pipeline distinguish these localizations?</p>
<p>Answer 2:</p>
<p>The reviewer raises an interesting question regarding the Rab27A staining. For your first point, we have purposely chosen Rab27a because, depending on its activation state, it is present on WPBs (GTP-bound) or in the cytosol (GDP-bound) (Kat et al., Blood Advances, 2021). Since not the entire pool of Rab27A present in the cell is in its active state, the “background” Rab27A staining is actually to be expected. </p>
<p>Regarding the second point, vesicles within the WPBs, such as the CD63-enriched intraluminal vesicles (ILVs) previously reported by Streetley et al. (Streetley et al., Blood, 2019) cannot be distinguished with the current pipeline. However, by adding modules, the pipeline could in principle be adjusted for this purpose by identifying the WPBs as parent object and using a secondary signal (e.g. CD63) to identify separate objects within the WPB. For this, it is important that the resolution should be sufficiently high to distinguish ILV-like structures within WPBs, which may require super resolution techniques such as Structured Illumination Microscopy. This is beyond the scope of this manuscript. However, our OrganelleProfiler and OrganelleContentProfiler are free to use and modify for specific research questions and we would like to encourage colleagues in the community to modify and expand the pipelines for their own requirements. </p>
<p>3. Although the 2 groups of ECFCs are clearly different in their morphology and content, which provides more evidence on the heterogeneity of ECFCs it would be interesting to show that the pipeline can distinguish the morphological parameters after treatment of e.g. group 1 ECFCs with nocodazole that disrupts the Golgi ribbon and results in shorter WPBs.</p>
<p>Answer 3:</p>
<p>We have performed an additional experiment on group 1 ECFCs and stained WPBs after 46 hours of nocodazole exposure, which led to fragmented Golgis and smaller WPBs. The OP pipeline was able to successfully quantify the difference in WPB length and eccentricity. This data is added to the manuscript as figure 5.</p>
<p>4. As the authors showed that the pipeline can very nicely indicate the distance of the organelle to the nucleus and cell membrane, it would be very interesting to show the distance to the nucleus and cell membrane after activation of ECFCs with different stimuli. The authors have previously shown very nicely that for example cAMP signaling can induce WPB perinuclear clustering. Does the pipeline can make these distinctions?</p>
<p>Answer 4:</p>
<p>We have performed a stimulation assay on ECFCs using forskolin in combination with IBMX, which has previously been shown to induce WPB clustering in HUVECs (Rondaij et al, ATVB, 2006). After 30 minutes we observed clustering of the WPBs and using the OP pipeline we have quantified this difference between a control and stimulated condition. The data has been added to the manuscript and can be seen in figure 6.</p>
<p>There are also 2 minor comments:</p>
<p>1. It is not shown on the graphs how many points there are per bar. When there are very big data sets even small differences can be statistically significant even though there is a minor change (e.g. length of the WPBs between group 1 and 3).</p>
<p>Answer:</p>
<p>We apologize for not indicating the number of data points in our graphs. We have added this information in the figure legends to ensure transparency.</p>
<p>2. The authors showed there are less cells per field of view between group 1 and 3 with group 3 cells being significantly larger in cell area. Does correction for the larger cell area normalizes the cell count per field of view?</p>
<p>Answer:</p>
<p>The reviewer is right that there are less cells per field of view in group 3 than in group 1 (Figure 3B), although both formed confluent monolayers. Group 3 cells were on average significantly larger (Figure 3C) and indeed, when correcting for increased cell size the cell count normalizes.</p>
<supplementary-material id="pone.0278009.s009" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0278009.s009" xlink:type="simple">
<label>Attachment</label>
<caption>
<p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p>
</caption>
</supplementary-material>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0278009.r003" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0278009.r003</article-id>
<title-group>
<article-title>Decision Letter 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Alfonso</surname>
<given-names>Julieta</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2023</copyright-year>
<copyright-holder>Julieta Alfonso</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0278009" document-id-type="doi" document-type="article" id="rel-obj003" link-type="peer-reviewed-article"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">3 May 2023</named-content>
</p>
<p>Automated segmentation and quantitative analysis of organelle morphology, localization and content using CellProfiler</p>
<p>PONE-D-22-30713R1</p>
<p>Dear Dr. Bierings,</p>
<p>Thank you for re-submission. You have successfully addressed all reviewer's concerns and I am very satisfied with the new version of your study.</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link ext-link-type="uri" xlink:href="http://www.editorialmanager.com/pone/" xlink:type="simple">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email xlink:type="simple">authorbilling@plos.org</email>.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email xlink:type="simple">onepress@plos.org</email>.</p>
<p>Kind regards,</p>
<p>Julieta Alfonso, Ph.D.</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0278009.r004" specific-use="acceptance-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0278009.r004</article-id>
<title-group>
<article-title>Acceptance letter</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Alfonso</surname>
<given-names>Julieta</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2023</copyright-year>
<copyright-holder>Julieta Alfonso</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0278009" document-id-type="doi" document-type="article" id="rel-obj004" link-type="peer-reviewed-article"/>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">6 Jun 2023</named-content>
</p>
<p>PONE-D-22-30713R1 </p>
<p>Automated segmentation and quantitative analysis of organelle morphology, localization and content using CellProfiler </p>
<p>Dear Dr. Bierings:</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
<p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email xlink:type="simple">onepress@plos.org</email>.</p>
<p>If we can help with anything else, please email us at <email xlink:type="simple">plosone@plos.org</email>. </p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
<p>Kind regards, </p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Julieta Alfonso </p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
</body>
</sub-article>
</article>